Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Future Microbiology|March 25, 2017
Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in miceCéline Ducournau, Thi Tl Nguyen, Rodolphe Carpentier, et al.
Frontiers in Immunology|May 7, 2019
Blockade of IL-33R/ST2 Signaling Attenuates <i>Toxoplasma gondii</i> Ileitis Depending on IL-22 ExpressionBernhard Ryffel, Feng Huang, Pauline Robinet, et al.
Molecular Therapy. Oncology|April 16, 2025
<i>Neospora caninum</i> as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapyClément Riviere, Muna Aljieli, Marie-Noëlle Mévélec, et al.
European Journal of Medicinal Chemistry|December 3, 2014
A small-molecule cell-based screen led to the identification of biphenylimidazoazines with highly potent and broad-spectrum anti-apicomplexan activityEspérance Moine, Caroline Denevault-Sabourin, Françoise Debierre-Grockiego, et al.
Frontiers in Immunology|November 16, 2020
Corrigendum: Blockade of IL-33R/ST2 Signaling Attenuates <i>Toxoplasma gondii</i> Ileitis Depending on IL-22 ExpressionBernhard Ryffel, Feng Huang, Pauline Robinet, et al.
The Journal of Infectious Diseases|March 17, 2021
Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital ToxoplasmosisAnne di Tommaso, Matthieu O Juste, Zineb Lakhrif, et al.
Bioconjugate Chemistry|October 25, 2018
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in VitroNicolas Aubrey, Emilie Allard-Vannier, Camille Martin, et al.
International Journal for Parasitology|March 11, 2018
Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosisEspérance Moine, Nathalie Moiré, Isabelle Dimier-Poisson, et al.
Cells|June 19, 2024
Specific Cell Targeting by <i>Toxoplasma gondii</i> Displaying Functional Single-Chain Variable Fragment as a Novel Strategy; A Proof of PrincipleMuna Aljieli, Clément Rivière, Louis Lantier, et al.
Antibodies (Basel, Switzerland)|April 25, 2020
Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region SequencesThomas Cnudde, Zineb Lakhrif, Justine Bourgoin, et al.
Pageof 8